Dolat Capital analyst Rashmi Shetty downgraded Natco Pharma Ltd (NTCPH:IN) from Reduce (3) to Sell (4) with a price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE